Aclaris Therapeutics (ACRS) Long-Term Investments (2014 - 2026)
Aclaris Therapeutics' Long-Term Investments was $79.07 million in Q2 2026, down 2.5% from $81.08 million a year earlier and down 7.4% from the prior quarter.
Powered by 
Analysis
Aclaris Therapeutics (ACRS) Long-Term Investments (2014 - 2026) Analysis & Trends
At the end of FY2025, Long-Term Investments at Aclaris Therapeutics came in at $60.61 million, down 32.9% from FY2024.
- Long-Term Investments shows a four-year compound annual growth rate of 15.3% (FY2021 to FY2025).
- In earlier years, Long-Term Investments was $90.3 million in FY2024 (+43.9%), $62.77 million in FY2023 (+412.8%), $12.24 million in FY2022 (-64.2%) and $34.24 million in FY2021.
- Quarterly Long-Term Investments has moved between $7.22 million (Q2 2022) and $90.99 million (Q2 2023) over five years.
- Compared with a year earlier, Long-Term Investments was higher in five of the last eight quarters, with growth averaging 35.6%.
- The best year-over-year quarter for Long-Term Investments over five years was Q4 2023 (growth of 412.8%); the worst was Q2 2022 (a decline of 79.1%).
- Per Business Quant data, ACRS's Long-Term Investments in the three quarters before Q2 2026 was $85.37 million (Q1 2026), $60.61 million (Q4 2025) and $71.3 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 266.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.22 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 69.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 2.62 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | - |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 1.56 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 5.79 Bn |
| 10 | Aclaris Therapeutics | 735.48 Mn | 735.48 Mn | 1.41 Mn | 79.07 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 79.07 Mn |
| Mar 31, 2026 | 85.37 Mn |
| Dec 31, 2025 | 60.61 Mn |
| Sep 30, 2025 | 71.30 Mn |
| Jun 30, 2025 | 81.08 Mn |
| Mar 31, 2025 | 85.21 Mn |
| Dec 31, 2024 | 90.30 Mn |
| Sep 30, 2024 | 45.71 Mn |
| Jun 30, 2024 | 38.78 Mn |
| Mar 31, 2024 | 33.20 Mn |
| Dec 31, 2023 | 62.77 Mn |
| Sep 30, 2023 | 83.94 Mn |
| Jun 30, 2023 | 90.99 Mn |
| Mar 31, 2023 | 33.60 Mn |
| Dec 31, 2022 | 12.24 Mn |
| Jun 30, 2022 | 7.22 Mn |
| Mar 31, 2022 | 23.96 Mn |
| Dec 31, 2021 | 34.24 Mn |
| Sep 30, 2021 | 45.74 Mn |
| Jun 30, 2021 | 34.50 Mn |
API Access
Aclaris Therapeutics Long-Term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-investments&ticker=ACRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-investments", "ticker": "ACRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=long-term-investments&ticker=ACRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();